05-17-2021, 06:47 PM
it's crucial to approach discussions about prognosis with sensitivity, as it can be a difficult topic for patients and their be loved ones. while phase 4 lung cancer is associated with a reduce survival rate, advances in therapy choices, including targeted therapies and immunotherapy, have enhanced outcomes for any patients.